Delcath jobs ‘first of many’ says Nolan

Tánaiste Eamon Gilmore officially opens the Galway headquarters of Delcath Systems. Delcath is the developer of the Hepatic CHEMOSAT® Delivery System, a device used in a new therapeutic approach for patients with cancers in the liver.

Tánaiste Eamon Gilmore officially opens the Galway headquarters of Delcath Systems. Delcath is the developer of the Hepatic CHEMOSAT® Delivery System, a device used in a new therapeutic approach for patients with cancers in the liver.

The recent announcement of 30 jobs at Delcath Systems is the first stage of a much larger plan for Galway according to local Labour TD Derek Nolan.

Dep Nolan has said the announcement “paves the way for a significant manufacturing and services hub for the company”, whose EU headquarters is based in Mervue.

According to Dep Nolan, Delcath’s new product, a method of treating liver cancer has accreditation worldwide, except for the USA where the application is still being processed.

“This means Galway will not only be the EU hub, but the worldwide hub exporting to markets like Canada and Australia,” he said. “The exciting potential is that as the facility develops in Galway, it is anticipated to move greater manufacturing jobs to the Galway plant.”

Dep Nolan believes this will provide a broad array of jobs from medical, engineering, administration, and manufacturing.

“It is also hoped this innovative approach to cancer treatment can be expanded to organs other than the liver and that these products can be developed in Galway,” he said. “The long term commitment to Galway offers huge potential for medium and long term significant job creation.”

Dep Nolan pointed out that more than 1,200 jobs have been announced in Galway so far this year, “surging ahead of the national average”.

“While unemployment remains too high in Galway,” he said, “these announcements show Galway has a real and bright future as a location for investment which in turn helps local businesses.”

 

Page generated in 0.7850 seconds.